Insider Trading30 Sept 2026, 05:40 pm
Natco Pharma Closes Trading Window for Insider Trading
AI Summary
Natco Pharma Ltd has announced the closure of its trading window for dealing in the company's securities. This restriction applies to Directors, Designated Persons, their immediate relatives, and other connected persons as per SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be closed effective October 1, 2026, and will reopen 48 hours after the declaration of the Unaudited Financial Results for the quarter ending September 30, 2026. The exact date of the board meeting to approve these results will be communicated later.
Key Highlights
- Trading window closed for directors and designated persons.
- Restriction effective from October 1, 2026.
- Window reopens 48 hours post Q3 FY27 results declaration.
- Purpose is to comply with SEBI Insider Trading Regulations.
Price Impact
More from NATCOPHARM